IFN-γ production from PBMCs by OK-432 treatment was suppressed by CM and was rescued by rIL-12 treatment, suggesting a possible new therapy against oral cancer with the combination IL-12 and OK-432. Here, IFNG is linked to lip and oral cavity carcinoma.